Vera Therapeutics (VERA) Interest Coverage Ratio (2020 - 2026)
Vera Therapeutics (VERA) reported Interest Coverage Ratio of 68.64 for Q1 2026, down 115.06% on a YoY basis from 455.64 in Q1 2025, and down 38.73% quarter-over-quarter from 49.48 in Q4 2025.
Vera Therapeutics (VERA) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Vera Therapeutics has reported Interest Coverage Ratio for 7 years, with the latest figure at 68.64 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 115.06% year-over-year to 68.64; the trailing twelve-month figure through Mar 2026 stood at 50.71 (down 556.31% YoY), and the FY2025 full-year result was 41.89, down 899.82% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 68.64, down from 49.48 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 64.47 in Q4 2022, with the low at 171.73 in Q3 2022.
- Historically, Interest Coverage Ratio has averaged 38.3 across 5 years, with a median of 31.92 in 2025.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio jumped 107.77% — and 2025, when it sank 207.26%.
- Vera Therapeutics' Interest Coverage Ratio stood at 64.47 in 2022, then slipped by 19.47% to 51.92 in 2023, then slipped by 11.15% to 46.13 in 2024, then slumped by 207.26% to 49.48 in 2025, then tumbled by 38.73% to 68.64 in 2026.
- The last three Interest Coverage Ratio figures came in at 68.64 (Q1 2026), 49.48 (Q4 2025), and 42.82 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Vera Therapeutics | 2.51 Bn | 1.91 Bn | - | -68.64 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.64 |
| Dec 31, 2025 | -49.48 |
| Sep 30, 2025 | -42.82 |
| Jun 30, 2025 | -42.76 |
| Mar 31, 2025 | -31.92 |
| Dec 31, 2024 | 46.13 |
| Sep 30, 2024 | -25.72 |
| Jun 30, 2024 | -19.53 |
| Mar 31, 2024 | -16.32 |
| Dec 31, 2023 | 51.92 |
| Sep 30, 2023 | -23.07 |
| Jun 30, 2023 | -24.04 |
| Mar 31, 2023 | -35.76 |
| Dec 31, 2022 | 64.47 |
| Sep 30, 2022 | -171.73 |
| Jun 30, 2022 | -117.63 |
| Mar 31, 2022 | -144.25 |
| Dec 31, 2021 | -829.25 |
| Dec 31, 2020 | -2,837.33 |
| Sep 30, 2020 | -63.08 |